Literature DB >> 3871601

Lymphopenia and abnormal balance of T-lymphocyte subpopulations in toxic epidermal necrolysis.

J C Roujeau, S Moritz, J C Guillaume, C Bombal, J Revuz, B Weil, R Touraine.   

Abstract

A lymphopenia (peripheral-blood-lymphocyte count less than 1,000/mm3) was observed in seven out of ten patients with toxic epidermal necrolysis (TEN). The enumeration of T-lymphocyte subsets with monoclonal antibodies showed a decreased number of pan T-lymphocytes (OKT3-positive), which was related to a profound depletion of OKT4-positive cells. In contrast, OKT8-positive cell counts were not significantly changed. This abnormal balance of T-lymphocytes was linked to the acute phase of the disease and was not found after recovery. The pathogenetic mechanisms of such T-lymphocyte abnormalities in TEN remain unclear.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871601     DOI: 10.1007/bf00406477

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  22 in total

1.  Fatal graft-versus-host disease after a small leukocyte transfusion in a patient with lymphoma and varicella.

Authors:  J Betzhold; R Hong
Journal:  Pediatrics       Date:  1978-07       Impact factor: 7.124

2.  Toxic epidermal necrolysis from graft-vs-host disease. Occurrence in a patient with thymic hypoplasia.

Authors:  J R McCarty; S S Raimer; M Jarratt
Journal:  Am J Dis Child       Date:  1978-03

3.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

4.  Toxic epidermal necrolysis in a patient with graft-vs-host reaction.

Authors:  G L Peck; G P Herzig; P M Elias
Journal:  Arch Dermatol       Date:  1972-04

5.  Incidence of circulating antibodies reactive with basal cells of skin in drug reactions.

Authors:  T van Joost
Journal:  Acta Derm Venereol       Date:  1974       Impact factor: 4.437

6.  Toxic epidermal necrolysis and homologous disease in hamsters.

Authors:  R E Billingham; J W Streilein
Journal:  Arch Dermatol       Date:  1968-11

7.  Lymphopenia in acute nitrofurantoin pleuropulmonary reactions.

Authors:  M Geller; D K Flaherty; H A Dickie; C E Reed
Journal:  J Allergy Clin Immunol       Date:  1977-06       Impact factor: 10.793

8.  Skin rash with infectious mononucleosis and ampicillin.

Authors:  B M Patel
Journal:  Pediatrics       Date:  1967-11       Impact factor: 7.124

9.  T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets.

Authors:  K Atkinson; J A Hansen; R Storb; S Goehle; G Goldstein; E D Thomas
Journal:  Blood       Date:  1982-06       Impact factor: 22.113

10.  Human graft versus host disease.

Authors:  R Parkman; J Rappeport; F Rosen
Journal:  J Invest Dermatol       Date:  1980-05       Impact factor: 8.551

View more
  5 in total

1.  Sjögren-like pluriglandular exocrine insufficiency after drug-induced toxic epidermal necrolysis.

Authors:  J Sabán; J R Pais; J L Rodríguez; D Boixeda
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 2.  Clinical features and management of severe dermatological reactions to drugs.

Authors:  M C Raviglione; A Pablos-Mendez; R Battan
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

3.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

4.  Staphylococcal Scalded Skin Syndrome: Criteria for Differential Diagnosis from Lyell's Syndrome. Two Cases in Adult Patients.

Authors:  B Napoli; N D'Arpa; L D'Amelio; S Chimenti; D Pileri; A Accardo-Palumbo; F Conte
Journal:  Ann Burns Fire Disasters       Date:  2006-12-31

Review 5.  Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.

Authors:  Teresa Bellón
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.